All News
Cognitive Impairment: The Hidden Burden in Lupus Care
Suppose you have a patient with lupus returning for follow-up. Their joint symptoms are well controlled. The kidneys—managed with a combination of biologic DMARD and mycophenolate—show no signs of active urinary sediment or protein. Yet, during the routine visit, your patient brings up fatigue and difficulty remembering things. How do you address this? Several studies presented at ACR24 focused on cognitive impairment in lupus.
Read ArticleACR 2024 - Day 3 Report
Highlights from Day 3 at ACR24 included the plenary session presentation on Nipocalimab (previously reviewed), but the big highlight was the Lupus Nephritis guideline recommendations.
Read Article
Akhil Sood MD AkhilSoodMD ( View Tweet)
Janet Pope Janetbirdope ( View Tweet)
Links:
Links:
Links:
Mrinalini Dey DrMiniDey ( View Tweet)
Links:
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
Links:
Bella Mehta bella_mehta ( View Tweet)
Links:
Links:
Janet Pope Janetbirdope ( View Tweet)
Links:
Links:


